Effects of beta-adrenergic blocking agents on peripheral vascular resistance
- PMID: 32434
- DOI: 10.1007/BF01477458
Effects of beta-adrenergic blocking agents on peripheral vascular resistance
Abstract
The effects of the beta-adrenergic blocking agents propranolol, pindolol, atenolol, bunitrolol, and methypranol on the vascular resistance of isolated perfused hindlimbs of rats were investigated. At concentrations of 0.01 microgram/ml in the perfusate dl-propranolol and pindolol significantly increased vascular resistance by blockade of beta2-receptor mediated vasodilatation, whereas atenolol, bunitrolol and methypranol had no effect on peripheral resistance at this concentration. With increasing concentrations up to 10 microgram/ml all drugs, with the exception of atenolol, caused vasodilatation. We conclude that the specificity of beta-blocking agents can be established in the isolated perfused hindlimb vasculature of rats through its effect on vascular resistance. The lack of inhibition of vascular beta2-receptors at low concentrations of atenolol and also bunitrolol and methypranol show relative selectivity for beta1-receptors. The differential effects of beta-adrenergic agents on vascular resistance may have significance for the clinical use of the drugs.
Similar articles
-
Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.Naunyn Schmiedebergs Arch Pharmacol. 1981 Feb;316(1):19-23. doi: 10.1007/BF00507221. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6116195
-
A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.J Pharmacobiodyn. 1981 Jul;4(7):475-82. doi: 10.1248/bpb1978.4.475. J Pharmacobiodyn. 1981. PMID: 6117611
-
β1- and β1/β2-adrenergic receptor antagonists block 6-nitrodopamine-induced contractions of the rat isolated epididymal vas deferens.Naunyn Schmiedebergs Arch Pharmacol. 2022 Oct;395(10):1257-1268. doi: 10.1007/s00210-022-02268-6. Epub 2022 Jul 8. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35798982
-
beta-Adrenoceptor antagonists: new drugs and new indications.N Engl J Med. 1981 Aug 27;305(9):500-6. doi: 10.1056/NEJM198108273050907. N Engl J Med. 1981. PMID: 6114433 Review. No abstract available.
-
Comparative review of beta-blocking agents.Conn Med. 1984 Apr;48(4):213-5. Conn Med. 1984. PMID: 6143648 Review. No abstract available.
Cited by
-
Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.J Mol Model. 2016 Dec;22(12):296. doi: 10.1007/s00894-016-3159-x. Epub 2016 Nov 26. J Mol Model. 2016. PMID: 27889884